Bellecapital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97M Buy
11,680
+208
+2% +$48.5K 0.47% 42
2026
Q1
$2.8M Sell
11,472
-3,717
-24% -$866K 0.51% 41
2025
Q4
$3.14M Buy
15,189
+1,091
+8% +$216K 0.56% 37
2025
Q3
$2.61M Buy
14,098
+6,747
+92% +$1.16M 0.42% 37
2025
Q2
$1.12M Hold
7,351
0.2% 57
2025
Q1
$1.22M Sell
7,351
-1,194
-14% -$187K 0.24% 57
2024
Q4
$1.24M Sell
8,545
-90
-1% -$13.9K 0.22% 60
2024
Q3
$1.4M Buy
8,635
+764
+10% +$122K 0.28% 59
2024
Q2
$1.15M Sell
7,871
-41
-0.5% -$6.1K 0.24% 62
2024
Q1
$1.25M Buy
7,912
+238
+3% +$37.9K 0.28% 59
2023
Q4
$1.2M Sell
7,674
-652
-8% -$100K 0.27% 58
2023
Q3
$1.3M Sell
8,326
-439
-5% -$72.4K 0.33% 57
2023
Q2
$1.45M Sell
8,765
-617
-7% -$99.6K 0.35% 55
2023
Q1
$1.45M Buy
9,382
+658
+8% +$106K 0.36% 58
2022
Q4
$1.54M Sell
8,724
-550
-6% -$95K 0.43% 49
2022
Q3
$1.51M Sell
9,274
-2,594
-22% -$439K 0.46% 47
2022
Q2
$2.11M Sell
11,868
-761
-6% -$136K 0.59% 46
2022
Q1
$2.24M Buy
12,629
+4
+0% +$681 0.71% 36
2021
Q4
$2.16M Buy
12,625
+4
+0% +$655 0.62% 41
2021
Q3
$2.04M Buy
12,621
+4
+0% +$682 0.62% 42
2021
Q2
$2.08M Buy
12,617
+4
+0% +$662 0.63% 38
2021
Q1
$2.07M Sell
12,613
-592
-4% -$95.8K 0.65% 37
2020
Q4
$2.08M Buy
13,205
+515
+4% +$76K 0.69% 40
2020
Q3
$1.89M Buy
12,690
+4,469
+54% +$661K 0.86% 31
2020
Q2
$1.16M Sell
8,221
-46
-0.6% -$6.7K 0.54% 41
2020
Q1
$1.08M Buy
8,267
+199
+2% +$28.2K 0.69% 35
2019
Q4
$1.18M Buy
8,068
+379
+5% +$51.4K 0.6% 38
2019
Q3
$995K Buy
7,689
+1,090
+17% +$144K 0.6% 38
2019
Q2
$919K Buy
6,599
+1,100
+20% +$152K 0.57% 37
2019
Q1
$769K Hold
5,499
0.49% 45
2018
Q4
$710K Buy
5,499
+2,505
+84% +$349K 0.51% 40
2018
Q3
$414K Buy
2,994
+100
+3% +$13.3K 0.27% 60
2018
Q2
$351K Hold
2,894
0.25% 59
2018
Q1
$371K Buy
+2,894
New +$391K 0.35% 56
2017
Q4
Sell
-8,669
Closed -$1.13M 79
2017
Q3
$1.13M Sell
8,669
-1,130
-12% -$150K 1.33% 25
2017
Q2
$1.3M Sell
9,799
-511
-5% -$65.2K 1.14% 25
2017
Q1
$1.28M Sell
10,310
-8,269
-45% -$988K 1.19% 26
2016
Q4
$2.14M Buy
18,579
+6,374
+52% +$736K 1.91% 20
2016
Q3
$1.4M Buy
12,205
+695
+6% +$84.3K 1.56% 20
2016
Q2
$1.4M Buy
11,510
+985
+9% +$112K 1.53% 21
2016
Q1
$1.1M Hold
10,525
1.47% 22
2015
Q4
$1.08M Buy
10,525
+1,100
+12% +$111K 1.38% 23
2015
Q3
$880K Sell
9,425
-1,210
-11% -$117K 1.3% 24
2015
Q2
$1.04M Buy
10,635
+3,480
+49% +$348K 1.33% 21
2015
Q1
$720K Buy
7,155
+1,545
+28% +$157K 0.96% 28
2014
Q4
$587K Sell
5,610
-2,909
-34% -$307K 0.8% 33
2014
Q3
$908K Sell
8,519
-4,320
-34% -$448K 1.06% 25
2014
Q2
$1.34M Sell
12,839
-1,085
-8% -$110K 1.32% 18
2014
Q1
$1.37M Buy
13,924
+6,160
+79% +$571K 1.19% 21
2013
Q4
$711K Buy
+7,764
New +$716K 0.68% 39

Other funds holding JNJ

Bellecapital's JNJ Position: Q2 2026 in Review

Bellecapital increased its Johnson & Johnson (JNJ) stake by 1.8% in Q2 2026, buying an estimated $48.5K and bringing the position to 11,680 shares worth $2.97M. The position accounts for 0.47% of the portfolio, ranked #42.

Bellecapital first reported a position in JNJ in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.14M in Q4 2025. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Bellecapital held 11,680 shares of Johnson & Johnson worth $2.97M as of Q2 2026.
  • Bellecapital bought 208 Johnson & Johnson shares in Q2 2026, an estimated $48.5K.
  • Johnson & Johnson made up 0.47% of Bellecapital's portfolio in Q2 2026, its #42 holding.
  • Bellecapital first reported a position in Johnson & Johnson in Q4 2013 and has held it in 50 quarters since.
  • Bellecapital's Johnson & Johnson position peaked at $3.14M in Q4 2025.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Bellecapital's 13F filing for Q2 2026, filed 22 Jul 2026.